
GC69856
Sampatrilat
Also known as (2S)-2-[[[(2S)-6-amino-2-(methanesulfonamido)hexanoyl]amino]methyl]-3-[1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl]cyclopentyl]propanoic acid
Sampatrilat (UK-81252) is a potent orally active vasopeptidase inhibitor that inhibits both angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP)· Sampatrilat has 12·4 times greater inhibition of C-domain ACE (Ki=13·8 nM) compared to N-domain ACE (Ki=171·9 nM)· Sampatrilat (UK-81252) can be used for research related to chronic heart failure and blood pressure regulation
- CAS number
- 129981-36-8
- Molecular weight
- 584.68
- Formula
- C26H40N4O9S
- Solubility
- DMSO : 100 mg/mL (171·03 mM; Need ultrasonic)
- InChIKey
- LPUDGHQMOAHMMF-JBACZVJFSA-N
- Catalogue number
- GC69856
- Brand
- GLPBIO
Computed properties PubChem CID 6324648 · XLogP -1.6 · TPSA 234 Ų · H-bond donors 7
- XLogP
- -1.6
- TPSA
- 234 Ų
- H-bond donors
- 7
- H-bond acceptors
- 11
- Rotatable bonds
- 17
- Heavy atoms
- 40
SMILES CS(=O)(=O)N[C@@H](CCCCN)C(=O)NC[C@H](CC1(CCCC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)C(=O)O
Computed descriptors from PubChem (CID 6324648), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il